Cerebrolysin vs Dihexa

Cerebrolysin wins for robust clinical track record, real human data, post-injury protocols, neuroprotection, and a tangible, multi-mechanism neurotrophic effect that persists for weeks post-cycle. Reliable dosing and sourcing, with safety well-charted (epilepsy excepted).

Dihexa wins for oral/sublingual convenience, potent synaptogenic mechanism (HGF/c-Met modulation), ease of stacking, and scenarios demanding sustained hippocampal plasticity—IF you accept the lack of human data and the HGF/cancer axis risk.

Pick Cerebrolysin if:

• You want a cycle-proven neurotrophic with real clinical data (TBI, post-stroke, age-related decline).
• You need post-injury cognitive restoration or insurance against AAS-/stimulant-induced neurotoxicity.
• You want a "brain reset" or mood lift every few months with long-lasting effects.
• You're comfortable with IM injections and can obtain legit product.
• You want effects that continue after the course and a predictable, safety-profiled outcome.

Pick Dihexa if:

• You need an orally (or sublingually) dosable plasticity enhancer without injections.
• You're targeting learning-phase cognitive ramp, skill acquisition, or post-psychedelic rebuild.
• You're ready to gamble on preclinical data, with no human outcome studies.
• You tolerate DMSO vehicles and can self-monitor for subtle effect.
• You have no personal/family history of c-Met-driven cancer and want the edge-case synaptogenic effect.